Evaluation of efficacy and safety of Beone Capsule as an immunity & energy booster for healthy body & mind in healthy individuals - A Randomized, Double Blind, Placebo controlled, Multi centric, Comparative, Prospective, Interventional, Clinical Study - NI

upin Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年4月3日

试验速览

暂无简介。

•1. Healthy individuals
•2. Subjects (for 18 years and above) who have taken at least one dose of
•COVID-19 vaccine.
•3. Subjects who are ready to provide written informed consent and who are ready to willingly participate and follow the protocol requirements of the clinical study.

•1. Pregnant and Lactating females
•2. Subjects who have been confirmed of having COVID-19 and have been isolated for its treatment. Subjects having recently (3 months) suffered and recovered of COVID-19 will also be excluded from the study
•3. Known cases of Diabetes
•4. Subjects having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening
•5. Subjects having immune compromised status like HIV, Hepatitis, Tuberculosis and Cancer etc.
•6. Subjects taking steroid treatment and or any kind of immunosuppressive therapy
•7. Subjects participating in any other clinical study or having participated in any other study 3 months prior to screening in the present study.
•8. Subjects having a past history of allergy to Beone Capsule or any of its ingredients
•9. Other conditions, which in the opinion of the investigators makes the patient unsuitable for enrolment or could interfere in adherence to of the study protocol.

发起方

upin Ltd